Weaning off heated humidified high flow nasal cannula successfully in a 24-week extreme low birth weight infant in South-South Nigeria: a case report

Izehiuwa G. Enato; Joseph Uduebor

doi:10.18203/2349-3291.ijcp20242264

Authors

Izehiuwa G. Enato Department of Paediatrics, Edo State University, Uzairue, Edo State, Nigeria
Joseph Uduebor Department of paediatrics, University Hospital of North Midlands, U.K.

DOI:

https://doi.org/10.18203/2349-3291.ijcp20242264

Keywords:

HHHFNC, High flow oxygen cannula, Prematurity, ELBW, Very low birth weight, RDS

Abstract

The use of heated humidified high flow nasal cannula (HHHFNC) has become increasingly popular for providing noninvasive respiratory support for neonates with respiratory distress syndrome (RDS). However, there are several challenges to its use as primary respiratory support in extreme low birth weight (ELBW) preterm infants delivered before 28 weeks gestational age (GA), these include: lack of established guideline; and conflicting reports from studies on the risk of respiratory failure (apnea), necrotizing enterocolitis (NEC), bronchopulmonary dysplasia (BPD) and death. In Nigeria, HHHFNC is not widely known nor used in most neonatal care facilities, including level III Neonatal care facilities. Despite adequate literature search, there is little or no known report or guideline for the successful use of and weaning from HHHFNC in ELBW neonates, delivered before 28 weeks GA in the Country. We present the successful weaning from HHHFNC as primary respiratory support at 30 weeks post conception age (PCA) in an ELBW preterm infant (weighing 700 gm) with severe RDS, delivered at 24 weeks GA in a neonatal care facility in Nigeria. HHHFNC was commenced at 6l/min following surfactant administration and successfully weaned off at 2l/min at 30 weeks PCA, with no incidence of apnea, BPD, NEC, air leaks, nasal septum damage and death. HHHFNC used as noninvasive primary respiratory support for ELBW preterm neonates with severe RDS delivered before 28 weeks GA is effective and safe; in addition, weaning off HHHFNC in this group of infants at 30 weeks PCA should be explored and recommended as a guideline in Nigeria and globally.

Metrics

Metrics Loading ...

References

Yadav S, Lee B, Kamity R. Neonatal Respiratory Distress Syndrome. Available at: https://www.ncbi.nlm.nih.gov/books/NBK560779/. Accessed on 08 January 2024.

Smith PB, Ambalavanan N, Li L, Cotton CM, Laughon M, Walsh MC, et al. Generic Database Subcommittee. Eunice Kennedy Shriver National Institute of Child Health Human Development Neonatal Research Network. Approach to infants born at 22 to 24 weeks' gestation: relationship to outcomes of more-mature infants. Paediatrics. 2012;129(6):e1508-16.

Mathai SS, Raju U, Kanitkar M. Management of respiratory distress in the newborn. Med J Armed Forces India. 2007;63(3):269-72.

Schoen K, Yu T, Stockmann C, Spigarelli MG, Sherwin CM. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity. Paediatr Drugs. 2014;16(2):169-77.

Ho JJ, Subramaniam P, Henderson-Smart DJ, Davis PG. Continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2015;7:CD002271.

Wilkinson D, Andersen C, O'Donnell CPF, De Paoli AG, Manley BJ. High flow nasal cannula for respiratory support in preterm infants. Cochrane Database Syst Rev. 2016;2(2):CD006405.

Yong SC, Chen SJ, Boo NY. Incidence of nasal trauma associated with nasal prong versus nasal mask during continuous positive airway pressure treatment in very low birthweight infants: a randomised control study. Arch Dis Child Fetal Neonatal Ed. 2005;90(6):F480-3.

Ola G El-Farghali. High-Flow Nasal Cannula in Neonates. Respiratory Care May. 2017;62(5):641-2.

Jatana KR, Oplatek A, Stein M, Phillips G, Kang DR, Elmaraghy CA. Effects of nasal continuous positive airway pressure and cannula use in the neonatal intensive care unit setting. Arch Otolaryngol Head Neck Surg. 2010;136(3):287-91.

Shoemaker MT, Pierce MR, Yoder BA, DiGeronimo RJ. High flow nasal cannula versus nasal CPAP for neonatal respiratory disease: A retrospective study. J Perinatol. 2007;27(2):85-91.

Roberts C, Manley B, Dawson J, Davis P. Nursing perceptions of high-flow nasal cannulae treatment for very preterm infants. J Paediatr Child Health. 2014;50(10):806-10.

Roberts CT, Owen LS, Manley BJ, et al. Nasal high-flow therapy for primary respiratory support in preterm infants. N Engl J Med. 2016;375(12):1142-51.

Lavizzari A, Colnaghi M, Ciuffini F, Chiara V, Stefano M, Ivan C, et al. Heated, Humidified High-Flow Nasal Cannula Vs Nasal Continuous Positive Airway Pressure for Respiratory Distress Syndrome of Prematurity: A Randomized Clinical Noninferiority Trial. JAMA Pediatr. 2016.

Dalal KT, Michael K, Jay SG, Kevin CD, Zubair HA. High Flow Nasal Cannula use Is Associated with Increased Morbidity and Length of Hospitalization in Extremely Low Birth Weight Infants. J Pediatr 2016;173:50-5.

Sand L, Szatkowski L, Kwok TC, Sharkey Don, Todd DA, Budge H. Observational cohort study of changing trends in non-invasive ventilation in very preterm infants and associations with clinical outcomes. Archives of Disease in childhood. Fetal Neonatal Edition. 2022;107(2):150-5.

Kotecha SJ, Adappa R, Gupta N, Watkins WJ, Kotecha S, Chakraborty M. Safety and Efficacy of High-Flow Nasal Cannula Therapy in Preterm Infants: A Meta-analysis. Pediatrics. 2015;136(3):542-53.

Shoemaker MT, Pierce MR, Yoder BA, DiGeronimo RJ. High flow nasal cannula versus nasal CPAP for neonatal respiratory disease: A retrospective study. J Perinatol. 2007;27(2):85-91.